These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 10529691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apheresis.
    Nilsson IM, Freiburghaus C.
    Adv Exp Med Biol; 1995; 386():175-84. PubMed ID: 8851026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).
    Jansen M, Schmaldienst S, Banyai S, Quehenberger P, Pabinger I, Derfler K, Hörl WH, Knöbl P.
    Br J Haematol; 2001 Jan; 112(1):91-7. PubMed ID: 11167789
    [Abstract] [Full Text] [Related]

  • 5. Immunoadsorption of factor VIII inhibitors.
    Freedman J, Garvey MB.
    Curr Opin Hematol; 2004 Sep; 11(5):327-33. PubMed ID: 15666656
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
    Huguet HC, Lasne D, Rothschild C, Siali R, Jozefonvicz J.
    Thromb Haemost; 2004 Feb; 91(2):259-66. PubMed ID: 14961152
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of hemophilia patients with inhibitors.
    Hedner U, Glazer S.
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1035-46. PubMed ID: 1400071
    [Abstract] [Full Text] [Related]

  • 12. Kinetic aspects of the removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption.
    Gjörstrup P, Berntorp E, Larsson L, Nilsson IM.
    Vox Sang; 1991 Oct; 61(4):244-50. PubMed ID: 1776241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR, UK Haemophilia Centre Doctors.
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract] [Full Text] [Related]

  • 15. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
    Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM.
    Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
    [No Abstract] [Full Text] [Related]

  • 16. Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).
    Knöbl P, Derfler K, Korninger L, Kapiotis S, Jäger U, Maier-Dobersberger T, Hörl W, Lechner K, Pabinger I.
    Thromb Haemost; 1995 Oct; 74(4):1035-8. PubMed ID: 8560408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.